Literature DB >> 2961497

Growth in an organ microenvironment as a selective process in metastasis.

J E Price1, S Naito, I J Fidler.   

Abstract

The purpose of these studies was to determine whether the ability of tumor cells to grow in an organ parenchyma selects for cells with enhanced potential to metastasize to this organ. B16-F1 melanoma cells (with low metastatic potential) were cultured in vitro on fragments of mouse lung or kidney suspended in medium supplemented with only 1 per cent fetal bovine serum. Seven days later, the organs were enzymatically dissociated and tumor cells recovered and expanded in monolayer culture. Tumor cells were then harvested and seeded onto fresh organ fragments. This sequence was repeated six times. The cells designated as B16 Lung-6 and B16 Kidney-6 were then injected intravenously into C57BL/6 mice and the number of experimental metastases counted after 21 days. B16 Lung-6 and, to a lesser degree, B16 Kidney-6 cells produced significantly more lung tumor colonies than B16-F1 cells. Some factor(s) in the organ environment did appear, therefore, to select out cells with greater metastatic potential from the low metastatic B16-F1. Forty-five clones of the B16-F1 melanoma, isolated by limiting dilution, were screened for their ability to grow on explants of mouse lung in a low-serum medium. Four clones exhibiting least growth and four clones exhibiting most growth, as assessed by examining histological sections of the lung explants, were injected intravenously into syngeneic mice. The eight clonal populations differed in experimental metastatic potential, but this behavior did not correlate with the ability of cells to grow in lung explants in vitro. The data suggest that selecting for cells with enhanced ability to grow in an organ is a necessary but not sufficient condition for isolating cells with high metastatic potential.

Entities:  

Mesh:

Year:  1988        PMID: 2961497     DOI: 10.1007/bf01580409

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  29 in total

Review 1.  Clinical and experimental studies on the biology of metastasis.

Authors:  D Tarin
Journal:  Biochim Biophys Acta       Date:  1985

2.  Lymphocyte adherence to high endothelial venules: characterization of a modified in vitro assay, and examination of the binding of syngeneic and allogeneic lymphocyte populations.

Authors:  E C Butcher; R G Scollay; I L Weissman
Journal:  J Immunol       Date:  1979-11       Impact factor: 5.422

3.  Organ-specific adhesion of metastatic tumor cells in vitro.

Authors:  P A Netland; B R Zetter
Journal:  Science       Date:  1984-06-08       Impact factor: 47.728

Review 4.  Cancer metastasis. Organ colonization and the cell-surface properties of malignant cells.

Authors:  G L Nicolson
Journal:  Biochim Biophys Acta       Date:  1982-12-21

5.  A cell-surface molecule involved in organ-specific homing of lymphocytes.

Authors:  W M Gallatin; I L Weissman; E C Butcher
Journal:  Nature       Date:  1983 Jul 7-13       Impact factor: 49.962

Review 6.  Cancer invasion and metastasis.

Authors:  I R Hart; I J Fidler
Journal:  Q Rev Biol       Date:  1980-06       Impact factor: 4.875

7.  Involvement of cell-cell adhesion molecules in liver colonization by metastatic murine lymphoma/lymphosarcoma variants.

Authors:  E J McGuire; J J Mascali; S R Grady; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1984 Jul-Sep       Impact factor: 5.150

Review 8.  'Seed and soil' revisited: mechanisms of site-specific metastasis.

Authors:  I R Hart
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

9.  In vivo isolation of a metastatic tumor cell variant involving selective and nonadaptive processes.

Authors:  A Raz; N Hanna; I J Fidler
Journal:  J Natl Cancer Inst       Date:  1981-01       Impact factor: 13.506

10.  Characterization of two highly metastatic variants of Lewis lung carcinoma with different organ specificities.

Authors:  P Brodt
Journal:  Cancer Res       Date:  1986-05       Impact factor: 12.701

View more
  13 in total

Review 1.  AACR centennial series: the biology of cancer metastasis: historical perspective.

Authors:  James E Talmadge; Isaiah J Fidler
Journal:  Cancer Res       Date:  2010-07-07       Impact factor: 12.701

Review 2.  Site-associated differences in cancer cell populations.

Authors:  L Weiss
Journal:  Clin Exp Metastasis       Date:  1991 May-Jun       Impact factor: 5.150

3.  Modulation of clonal progression in B16F1 melanoma cells.

Authors:  J F Harris; A F Chambers; A S Tam
Journal:  Clin Exp Metastasis       Date:  1991 Mar-Apr       Impact factor: 5.150

4.  Rapid extravasation and establishment of breast cancer micrometastases in the liver microenvironment.

Authors:  Michelle D Martin; Gert-Jan Kremers; Kurt W Short; Jonathan V Rocheleau; Lei Xu; David W Piston; Lynn M Matrisian; D Lee Gorden
Journal:  Mol Cancer Res       Date:  2010-08-19       Impact factor: 5.852

Review 5.  Isolated pancreatic metastases from renal cell carcinoma: an outcome of a special metastatic pathway or of specific tumor cell selection?

Authors:  Franz Sellner
Journal:  Clin Exp Metastasis       Date:  2018-06-12       Impact factor: 5.150

6.  Metastasizing lung carcinomas in Hann: Wistar rats.

Authors:  K Kamino; M Kohler; U Mohr
Journal:  Clin Exp Metastasis       Date:  1992-07       Impact factor: 5.150

7.  DNA ploidy of primary hepatocellular carcinoma and pulmonary metastases.

Authors:  Y Yoshida; T Kanematsu; D Korenaga; T Sonoda; K Sugimachi
Journal:  Clin Exp Metastasis       Date:  1992-09       Impact factor: 5.150

Review 8.  Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis.

Authors:  G L Nicolson
Journal:  Cancer Metastasis Rev       Date:  1993-09       Impact factor: 9.264

9.  The establishment of two cell lines from a mouse uterine cervical carcinoma (U14) and their metastatic phenotype changes.

Authors:  X M Yuan; F P Xie; Z B Lu; T X Wen; Y J Zhuang; A C Jones; Z Zhang
Journal:  Clin Exp Metastasis       Date:  1995-11       Impact factor: 5.150

Review 10.  FcR may function as a progression factor of nonlymphoid tumors.

Authors:  I P Witz; M Ran
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.